Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Sorrento Therapeutics, Inc. | Financial_Report.xls |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - Sorrento Therapeutics, Inc. | d270175dex321.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Sorrento Therapeutics, Inc. | d270175dex311.htm |
| EX-10.12 - THIRD AMENDMENT TO OFFICE LEASE - Sorrento Therapeutics, Inc. | d270175dex1012.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Sorrento Therapeutics, Inc. | d270175dex312.htm |
| EX-10.14 - FIFTH AMENDMENT TO OFFICE LEASE - Sorrento Therapeutics, Inc. | d270175dex1014.htm |
| EX-10.13 - FOURTH AMENDMENT TO OFFICE LEASE - Sorrento Therapeutics, Inc. | d270175dex1013.htm |
| 10-K - FORM 10-K - Sorrento Therapeutics, Inc. | d270175d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-163670 on Form S-8 of our report dated March 30, 2012, relating to the financial statements of Sorrento Therapeutics, Inc. for the year ended December 31, 2011, appearing in this Annual Report on Form 10-K of Sorrento Therapeutics, Inc.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 30, 2012